Summit Financial’s Insmed INSM Stock Holding History

Summit Financial’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$334K	Buy	2,040 +206	+11%	+$31.7K	﹤0.01%	1145
2025 Q4	$319K	Buy	+1,834	New	+$335K	﹤0.01%	1059

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Summit Financial's INSM Position: Q1 2026 in Review

Summit Financial increased its Insmed (INSM) stake by 11% in Q1 2026, buying an estimated $31.7K and bringing the position to 2,040 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

Summit Financial first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Summit Financial held 2,040 shares of Insmed worth $334K as of Q1 2026.
Summit Financial bought 206 Insmed shares in Q1 2026, an estimated $31.7K.
Insmed made up ﹤0.01% of Summit Financial's portfolio in Q1 2026, its #1145 holding.
Summit Financial first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.